Ajmeeta Sangtani

Title: Ajmeeta Sangtani: Innovator in Nanotechnology

Introduction

Ajmeeta Sangtani is a prominent inventor based in Columbia, MD (US). He has made significant contributions to the field of nanotechnology, particularly in the synthesis of gold nanoflowers. His innovative work has implications for drug delivery applications, showcasing the potential of nanoscale materials in medical science.

Latest Patents

Ajmeeta Sangtani holds a patent for the "Seedless synthesis of anisotropic gold nanoflowers with cellular control and drug delivery applications." This patent describes a novel method for synthesizing anisotropic nanoscale gold nanoflower (AuNF) particles using bidentate thiolate ligands. The process involves a combination of reagents, including ligands, ascorbic acid, and hydroxide, to produce AuNF with controlled size and anisotropic properties. Compared to prior art gold nanospheres, the AuNF produced demonstrates approximately a 15-fold improvement in a drug delivery assay.

Career Highlights

Ajmeeta Sangtani is currently associated with the United States Navy, where he contributes his expertise in nanotechnology. His work is instrumental in advancing the applications of nanomaterials in various fields, particularly in healthcare.

Collaborations

He has collaborated with notable colleagues, including Eunkeu Oh and Kimihiro Susumu, to further enhance the research and development of nanotechnology applications.

Conclusion

Ajmeeta Sangtani's innovative work in the synthesis of gold nanoflowers represents a significant advancement in nanotechnology, with promising applications in drug delivery. His contributions continue to shape the future of medical science through the use of nanoscale materials.